|
|
|
Volumn 21, Issue 128, 2012, Pages 150-
|
|
Drugs for Alzheimer's disease: Best avoided
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DONEPEZIL;
GALANTAMINE;
MEMANTINE;
NEW DRUG;
RIVASTIGMINE;
ALZHEIMER DISEASE;
BEHAVIOR DISORDER;
CAREGIVER BURDEN;
CLINICAL EVALUATION;
CLINICAL TRIAL (TOPIC);
COGNITIVE DEFECT;
DISEASE COURSE;
DISEASE SEVERITY;
DOPAMINERGIC ACTIVITY;
DRUG EFFICACY;
GASTROINTESTINAL DISEASE;
HEALTH INSURANCE;
HEART DISEASE;
HUMAN;
MEDICAL SOCIETY;
MENTAL DISEASE;
MORTALITY;
NEUROLOGIC DISEASE;
NEUROLOGIST;
ORGANIZATION AND MANAGEMENT;
PALLIATIVE THERAPY;
PSYCHIATRIST;
QUALITY OF LIFE;
REIMBURSEMENT;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
VOMITING;
ALZHEIMER DISEASE;
CHOLINESTERASE INHIBITORS;
HUMANS;
MEMANTINE;
|
|
EID: 84863539424
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (15)
|
|
References (5)
|
